To validate the FGFR2 microarray target data, A549, H1299, H322, and H460 NSCLC cells were transfected with TUSC2 plasmid, treated with 2.3μM erlotinib, and analyzed for FGFR2 expression by western blot. Here, FGFR2 is linked to non-small cell lung carcinoma.